Vikas Lifecare Limited has informed stock exchanges about receiving a significant income tax demand order worth ₹22.99 crore from the Income Tax Department. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Tax Demand Details

The company received the assessment order on March 27, 2026, covering various assessment years. The demand primarily stems from certain additions and disallowances made by Income Tax Authorities during assessment proceedings.

Company's Response Strategy

Vikas Lifecare Limited is currently evaluating the assessment order and plans to pursue appropriate legal remedies. The company intends to file appeals within the prescribed timelines based on its preliminary assessment of the order.

Financial Impact Assessment

The company has indicated that it is in the process of assessing the financial implications of the tax demand order. Key aspects of the impact include:

• No immediate material impact on company operations
• Assessment pending final adjudication of the matter
• Management confidence in favorable outcome at appellate stage
• Legal advice supporting the company's position

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (LODR) Regulations, 2015. This regulation requires listed companies to inform stock exchanges about material events that could impact their operations or financial position.

The company's management, led by Managing Director Sundeep Kumar Dhawan, has assured stakeholders that they are taking appropriate steps to address the tax demand through proper legal channels.

Vikas lifecare Limited has submitted its initial disclosure to stock exchanges confirming that it does not qualify as a Large Corporate under the recent SEBI regulatory framework. The company made this declaration in compliance with SEBI Circular SEBI/HO/DDHS/DDHSP/PODI/P/CIR/2023/172 dated October 19, 2023, which addresses fund raising through debt securities by large corporates.

Regulatory Compliance Disclosure

The pharmaceutical company formally communicated to both National Stock Exchange of India Limited and BSE Limited on April 13, 2026, that it does not meet the applicability criteria mentioned in clause 1.2 of Chapter XII of the aforementioned SEBI circular. This disclosure represents the initial reporting requirement for entities to clarify their status under the new regulatory framework.

Management Authorization

The disclosure was digitally signed and submitted by Sundeep Kumar Dhawan, Managing Director of Vikas Lifecare Limited, bearing DIN 09508137. The communication was addressed to the listing compliance departments of both major Indian stock exchanges where the company's shares are traded.

SEBI Circular Context

The SEBI circular SEBI/HO/DDHS/DDHSP/PODI/P/CIR/2023/172 specifically deals with fund raising by issuance of debt securities by large corporates and establishes disclosure and compliance requirements for such entities. Companies are required to make initial disclosures confirming whether they fall under the Large Corporate classification based on specified criteria.

This regulatory disclosure ensures transparency in the market regarding which entities are subject to the enhanced compliance requirements for debt securities issuance under the SEBI framework for large corporates.